Sphera Funds Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
Other funds holding PTLA
JSP
CCM
RSCM
Sphera Funds Management's PTLA Position: Q1 2020 in Review
Sphera Funds Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q1 2020, closing a stake of 317,000 shares — an estimated $7.57M sold.
Sphera Funds Management first reported a position in PTLA in Q4 2013 and held it in 16 quarters. The position peaked at $10.2M in Q4 2017. 187 funds tracked by Wall St. Rank hold PTLA as of Q1 2020.
- Sphera Funds Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
- Sphera Funds Management sold 317,000 Portola Pharmaceuticals, Inc. shares in Q1 2020, an estimated $7.57M.
- Sphera Funds Management first reported a position in Portola Pharmaceuticals, Inc. in Q4 2013 and held it in 16 quarters.
- Sphera Funds Management's Portola Pharmaceuticals, Inc. position peaked at $10.2M in Q4 2017.
- 187 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q1 2020.
Based on Sphera Funds Management's 13F filing for Q1 2020, filed 14 May 2020.